Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Operating Expenses: 2009-2025

Historic Operating Expenses for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to $167.1 million.

  • Myriad Genetics' Operating Expenses fell 1.59% to $167.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 96.04%. This contributed to the annual value of $708.9 million for FY2024, which is 8.46% down from last year.
  • Myriad Genetics' Operating Expenses amounted to $167.1 million in Q3 2025, which was down 65.26% from $481.0 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Operating Expenses registered a high of $481.0 million during Q2 2025, and its lowest value of -$8.2 million during Q4 2023.
  • For the 3-year period, Myriad Genetics' Operating Expenses averaged around $208.6 million, with its median value being $183.6 million (2024).
  • Per our database at Business Quant, Myriad Genetics' Operating Expenses slumped by 129.29% in 2023 and then spiked by 2,415.85% in 2024.
  • Myriad Genetics' Operating Expenses (Quarterly) stood at $203.9 million in 2021, then crashed by 86.27% to $28.0 million in 2022, then tumbled by 129.29% to -$8.2 million in 2023, then soared by 2,415.85% to $189.9 million in 2024, then dropped by 1.59% to $167.1 million in 2025.
  • Its last three reported values are $167.1 million in Q3 2025, $481.0 million for Q2 2025, and $163.2 million during Q1 2025.